Bedfont Scientific clears FDA follow-up audit

Bedfont Scientific, based in Harrietsham Kent, successfully passes another FDA inspection.

Bedfont Scientific, a local medical device manufacturer specialising in breath analysis, is pleased to announce that the US Food and Drug Administration (FDA) has completed a successful inspection at its premises.

The audit found Bedfont to be compliant with Good Manufacturing Practice (GMP), which means their products are manufactured to the highest quality which is essential when you’re providing technology that saves people’s lives.

We are really pleased the FDA follow-up audit went well and all previous observations were closed out. With this outcome, it shows we are working as a compliant company to FDA standards and are able to continue to provide high-quality products to the USA. We look forward to working with the FDA in the future and to continue building on our relationship with them.

Louise Bateman, QA & RA Manager at Bedfont Scientific.

Bedfont’s aim for the future with this clean bill of health is to continue with our scientific contributions to health, including research and development into new medical breath analysis applications, to help save peoples' lives, one breath at a time.

General Manager, Jason Smith.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bedfont® Scientific Ltd. (2019, June 18). Bedfont Scientific clears FDA follow-up audit. News-Medical. Retrieved on May 20, 2022 from https://www.news-medical.net/news/20161205/Bedfont-Scientific-clears-FDA-follow-up-audit.aspx.

  • MLA

    Bedfont® Scientific Ltd. "Bedfont Scientific clears FDA follow-up audit". News-Medical. 20 May 2022. <https://www.news-medical.net/news/20161205/Bedfont-Scientific-clears-FDA-follow-up-audit.aspx>.

  • Chicago

    Bedfont® Scientific Ltd. "Bedfont Scientific clears FDA follow-up audit". News-Medical. https://www.news-medical.net/news/20161205/Bedfont-Scientific-clears-FDA-follow-up-audit.aspx. (accessed May 20, 2022).

  • Harvard

    Bedfont® Scientific Ltd. 2019. Bedfont Scientific clears FDA follow-up audit. News-Medical, viewed 20 May 2022, https://www.news-medical.net/news/20161205/Bedfont-Scientific-clears-FDA-follow-up-audit.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Could FeNO breath testing provide an early indicator of Covid-19?